Kargluminsyre Waymade (Carglumic Acid)

Carglumic acid acts as a structural analogue of N‑acetylglutamate, the natural activator of carbamoyl phosphate synthetase I (CPS‑I). Binding to CPS‑I enhances its activity, promoting the conversion of ammonia and bicarbonate into carbamoyl phosphate, a key step in the urea cycle that facilitates the safe elimination of excess ammonia from the body.

The dosage of Kargluminsyre Waymade is individualized and determined by the prescribing clinician based on the patient’s age, weight, severity of hyperammonemia, and response to therapy. Healthcare professionals calculate the appropriate amount and frequency to achieve optimal ammonia control while minimizing adverse effects.

Safety data for carglumic acid in pregnancy and lactation are limited, and the product’s pregnancy category is not established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. After confirmation, the team provides pricing, availability, shipping details (including any cold‑chain requirements), and assists with import documentation.

The primary alternative to carglumic acid is sodium phenylbutyrate, which works by providing an alternative pathway for nitrogen excretion. Carglumic acid directly activates the urea cycle, whereas phenylbutyrate diverts nitrogen to alternative metabolites. Choice of therapy depends on the specific urea cycle defect, patient tolerance, and clinical response, and should be guided by a specialist.

Kargluminsyre Waymade should be stored at ambient temperature, below 25 °C, in its original container to protect it from moisture and direct sunlight. Keep the product out of reach of children and avoid exposure to extreme temperatures or humidity, which could compromise its stability.

The medication is taken orally, usually with a glass of water. It can be administered with or without food, but patients should follow the prescribing clinician’s instructions regarding timing relative to meals to ensure consistent absorption and therapeutic effect.

Serious adverse events, although rare, include severe allergic reactions (anaphylaxis), worsening hepatic encephalopathy, metabolic acidosis, hyperuricemia, and seizures. Patients should be monitored closely for any signs of these conditions, and immediate medical attention is required if they occur.

Kargluminsyre Waymade is contraindicated in individuals with a known hypersensitivity to carglumic acid or any of its excipients. It should also be avoided in patients with severe liver failure where the urea cycle cannot be restored, and in those where the risk of serious adverse reactions outweighs potential benefits, as determined by a healthcare professional.